From: Development and validation of the openness to the future scale: a prospective protective factor
General Population | Clinical Population | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Item | M (SD) | a | b1 | b2 | b3 | b4 | M (SD) | a | b1 | b2 | b3 | b4 |
1 | 3.98 (.84) | 1.48 | −6.24 | − 3.31 | − 1.89 | 1.46 | 3.18 (1.23) | 1.72 | −3.04 | −1.07 | .29 | 2.59 |
2 | 3.97 (.93) | 2.16 | −6.41 | − 3.61 | − 2.12 | 1.50 | 3.09 (1.26) | 2.28 | −3.22 | −1.05 | .55 | 3.05 |
3 | 3.89 (.91) | 1.68 | −5.66 | −3.17 | −1.67 | 1.69 | 2.76 (1.24) | 2.08 | −2.26 | −.27 | 1.15 | 3.92 |
4 | 4.02 (.94) | 1.47 | −5.06 | −3.35 | −1.54 | .91 | 3.10 (1.22) | 1.66 | −2.66 | −1.07 | .53 | 2.73 |
5 | 4.36 (.85) | 1.32 | −5.48 | −3.74 | −2.46 | −.17 | 3.32 (1.38) | 1.68 | −2.50 | −1.12 | −.17 | 1.67 |
6 | 3.60 (1.26) | .83 | −3.07 | −1.32 | −0.44 | .87 | 2.94 (1.41) | .63 | −1.52 | −.19 | .49 | 1.54 |
7 | 4.01 (.98) | 1.04 | −4.93 | −2.57 | −1.37 | .71 | 3.21 (1.35) | 1.59 | −2.49 | −1.05 | .22 | 1.86 |
8 | 4.27 (.78) | 2.46 | −8.62 | −5.70 | −3.48 | .57 | 3.42 (1.25) | 2.78 | −4.36 | −2.01 | −.34 | 2.61 |
9 | 4.11 (.99) | .92 | −4.57 | −2.63 | −1.45 | .35 | 3.83 (1.19) | 1.32 | −3.16 | −2.26 | −.91 | .82 |
10 | 4.07 (.82) | 1.36 | −5.46 | −3.93 | −1.96 | 1.06 | 3.45 (1.18) | 1.94 | −3.43 | −2.05 | −.32 | 2.36 |